Category Archives: DePuy Hip Recall
More Criticism for DePuy Orthopaedics and ASR Hip Replacement System
Recent information further implicates DePuy Orthopaedics for the problems associated with its ASR artificial hip replacement system. On September 27, 2011, the Australian Senate Community Affairs Committee conducted an inquiry into that country’s regulatory standards for medical devices. During the Senate hearing, witnesses testified that in 2006 DePuy had evidence…
DePuy and Broadspire’s Handling of ASR Artificial Hip Recall Claims Raising Concerns
When DePuy issued the United States recall of the ASR artificial hip systems, it announced that it would pay for the necessary, medical replacement treatment for patients suffering complications as a result of the ASR hip. But the manner in which DePuy is handling patient reimbursement is gaining criticism on…
DePuy Update: ASR Hip System Under Fire By FDA
On August 22, 2011 the NY times published the results of its own study of Adverse Event Reports to the Food and Drug Administration (FDA) by patients with metal on metal artificial hip systems. The results confirm widespread failures with the DePuy ASR hip system.
Read the full NY Times Hip…
Recalled DePuy Replacement Hip Failure Rate: Revised Data Released
Recalled DePuy Replacement Hip Failure Rate: Revised Data Released
In August of 2010, when DePuy first issued a voluntary recall of its ASR XL Acetabular and its ASR Hip Resurfacing Systems, DePuy referenced data suggesting a hip replacement revision rate of 13 percent, or 1 out of every 8 patients. (a…
DePuy Artificial Hip Recall and Massachusetts Product Liability Law
On August 24, 2010, DePuy Orthopaedics issued a voluntary recall of its ASR XL Acetabular Hip System and its ASR Hip Resurfacing System. In its recall notice, DePuy referenced data suggesting a higher than average revision rate (a revision is when a second surgical procedure is required to modify or replace…
